The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIbstock Regulatory News (IBST)

Share Price Information for Ibstock (IBST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 152.20
Bid: 152.60
Ask: 153.20
Change: -2.20 (-1.42%)
Spread: 0.60 (0.393%)
Open: 154.80
High: 155.20
Low: 152.20
Prev. Close: 154.40
IBST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Aug 2019 10:26

RNS Number : 5564H
Ibstock PLC
01 August 2019
 

1 August 2019

 

Ibstock plc

 

Director Change

 

 

Further to the announcement issued on 6 February 2019, Ibstock plc ('Ibstock' or the 'Company') announces that Chris McLeish has today been appointed a director of the Company.

 

Enquiries

Citigate Dewe Rogerson

Kevin Smith

Nick Hayns

+ 44 (0)20 7638 9571

 

 

 Notes to Editors:

Remuneration:

Chris McLeish's remuneration arrangements, which are consistent with the Directors' Remuneration Policy approved by shareholders, will take effect from 1 August 2019, as summarised below:

·;

Base salary - £300,000 p.a.;

·;

Pension - 10% of salary cash allowance;

·;

Annual bonus opportunity - up to 125% of salary; and

·;

Long Term Incentive Plan - 125% of salary for 2019 (normal award for 2019 is 100% of salary for Executive Directors). The increased quantum for 2019 was negotiated as part of Mr McLeish's recruitment from Tate & Lyle plc in lieu of one of the Tate & Lyle share awards which is not otherwise covered under the buy-out arrangements. From 2020 onwards awards of 150% of salary will be made, subject to performance

Chris also held a number of cash and share incentives under various Tate & Lyle plc incentive plans. In line with the approved Directors' Remuneration Policy, replacement awards form part of the recruitment remuneration.

A cash payment of £97,949 will be made to Chris on appointment to compensate the value of his 2018 annual bonus earned which was forfeited on cessation.

In addition, it has been agreed to grant a buy-out award of 60,393 Ibstock plc ordinary shares of 1p each. The award is to compensate, on a fair value basis, the value forgone by Chris McLeish for share awards forfeited on cessation of employment with his previous employer. The fair value of the award has been reduced to take account of the original performance period and the proportion of satisfaction of the performance conditions as at the time of the buy-out. The vesting level will be revisited at the time of vesting to adjust the number of Ibstock shares which vest to reflect the actual vesting of the original Tate & Lyle awards.

Full disclosure of these remuneration arrangements will be provided in the Directors' Remuneration Report to be published in 2020.

Ibstock plc is a leading manufacturer of clay bricks with a diversified range of clay and concrete products, and operations in the United Kingdom and the United States. Its principal products are clay bricks, brick components, concrete roof tiles, concrete substitutes for stone masonry, concrete fencing and general concrete building products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEANPFEASNEEF
Date   Source Headline
25th Apr 20247:00 amRNSFirst Quarter Trading Update
18th Apr 202411:00 amRNSHolding(s) in Company
11th Apr 20243:05 pmRNSNotice of AGM
4th Apr 20244:15 pmRNSDirector/PDMR Shareholding
25th Mar 202411:00 amRNSDirector/PDMR Shareholding
8th Mar 20244:25 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSPreliminary Results
22nd Jan 202410:00 amRNSHolding(s) in Company
19th Jan 20243:00 pmRNSHolding(s) in Company
17th Jan 20247:00 amRNSTrading Update
8th Jan 20244:09 pmRNSNotification of Trading Update
2nd Jan 20248:26 amRNSHolding(s) in Company
2nd Jan 20248:00 amRNSBlock Listing Six Monthly Return
18th Dec 20233:00 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 20234:30 pmRNSHolding(s) in Company
28th Sep 202310:47 amRNSHolding(s) in Company
26th Sep 202312:32 pmRNSNotification of Trading Statement
25th Aug 20232:00 pmRNSDirector/PDMR Shareholding
15th Aug 20233:30 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSInterim results
3rd Jul 20234:17 pmRNSBlock listing Interim Review
27th Jun 20233:30 pmRNSReport on Payments to Govts
22nd Jun 202312:00 pmRNSHolding(s) in Company
16th Jun 202310:00 amRNSHolding(s) in Company
4th May 20232:57 pmRNSDirector Declaration
2nd May 20232:00 pmRNSDirector/PDMR Shareholding
27th Apr 20232:00 pmRNSResult of AGM
27th Apr 20237:00 amRNSAGM Trading Update
20th Apr 20232:30 pmRNSDirector/PDMR Shareholding
4th Apr 202312:30 pmRNSDirector/PDMR Shareholding
24th Mar 202311:30 amRNSChange in External Directorships
23rd Mar 20232:00 pmRNSAnnual Report and Accounts and Notice of AGM
17th Mar 20232:30 pmRNSDirector/PDMR Shareholding
15th Mar 20239:00 amRNSDirectorate Change
8th Mar 20233:30 pmRNSDirectorate Change
8th Mar 20237:00 amRNSPreliminary Results
18th Jan 20237:00 amRNSTrading Update
18th Jan 20237:00 amRNSBlock listing Six Monthly Return
10th Jan 202310:30 amRNSNotification of Trading Statement
8th Dec 20224:55 pmRNSHolding(s) in Company
22nd Nov 202210:00 amRNSChange in External Directorships
10th Nov 20229:30 amRNSHolding(s) in Company
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 202212:00 pmRNSHolding(s) in Company
24th Oct 20227:00 amRNSTransaction in Own Shares
21st Oct 20227:00 amRNSTransaction in Own Shares
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
18th Oct 20227:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.